UNMOL (Urdu for Precious): Access to Cancer Medicines in Pakistan

Access Accelerated
A program offering a sustainable financial solution for those that cannot afford the out-of-pocket payments for oncology treatment in Pakistan.
Responsible for co-payment of treatment.
Government 1
Life Sciences 1

The objective of the Patient Support Programme in Pakistan is to enable low income patients to afford standard of care medicines to treat their cancers.

In order to help address multiple access challenges, Roche Pakistan launched its Patient Support Program for access to cancer medicines, called “UNMOL” (Urdu for “Precious”) in August 2017.

UNMOL offers support for two major hurdles in the patient journey.

Firstly, the program offers a sustainable financial solution for those in need of oncology treatment by providing free of cost medicines for different types of cancers.

It also offers face-to-face facilitation in public hospitals to help patients enrol in available public funding programs to cover treatment costs. One such public program is Sehat Sahulat, Pakistan’s Universal Healthcare program. In recent years Roche Pakistan has accelerated its efforts to provide standard-of- care cancer treatment to eligible patients through this programme.

Many of these patients were able to advance their treatment through Sehat Sahulat via UNMOL.

Results and milestones

More than 15,000 patients have been supported with cancer care since the launch of UNMOL, with 2200+ patients being helped through the Sehat initiative with a growing percentage of women.

Geographic Reach
  • Eastern Mediterranean
See Where
Disease Area
  • Non-communicable diseases
See Disease Areas
Target Population
  • People with low incomes
  • Women
SGDs the partnership contributes to
SDG 3: Good health and well-being
  1. 3.4: NCDs (including mental health)
  2. 3.8: Achieve universal health coverage
SDG 5: Gender equality
SDG 17: Partnerships for the goals 
Partner organizations

Federal government of Pakistan. Responsible for co-payment of treatment.

Life Sciences

Responsible for patient enrollment into the programme.

Additional information